Northrop Grumman posts Q3 2026 sales $11.12B, EPS $7.89; backlog rises to $109.6B
Northrop Grumman reported Q3 2026 sales of $11.12B, up 7% YoY, with EPS of $7.89. Net income was $1.124B, and adjusted free cash flow improved to $1.81B. Backlog grew to $109.6B. The company raised 2026 guidance for segment operating income and MTM-adjusted EPS, with sales growth across all sectors.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance lift are likely to boost the stock in the short term, while the expanding backlog supports longer‑term demand outlook.
Market read
Strong earnings and guidance raise make this a high‑impact event for the stock and the defense sector.
What to watch
Potential supply‑chain constraints or future defense budget cuts could temper upside.
Background
Northrop Grumman reported Q3 2026 results, showing revenue growth across all segments and a sizable backlog increase.
Ticker impact
Q3 2026 earnings released with higher sales, EPS and raised guidance, plus a growing backlog.
likely upward pressure as investors price in stronger sales and higher guidance
The company posted 7% revenue growth, EPS beat, and lifted 2026 operating income guidance, which typically drives buying.
Market effects
Defense and aerospace sector may see broader strength from Northrop's backlog growth.
U.S. defense stocks could rally in response to the earnings beat.
Limited to investors with exposure to U.S. defense contractors.
Counterpoint
If guidance raises are modest and backlog growth slows, the rally could be short‑lived.
Key entities
- companyNorthrop Grumman
U.S. defense and aerospace contractor.
